PDCD1 and Miyoshi myopathy: Altogether, this indicates that there is increased expression of the PD-1/PD-L1 pathway components in the BM microenvironment during MM progression, which may contribute to the gradual attenuation of T-cell mediated immune responses during the patient’s disease course [21].